Search
for
Sort by
Research 451–480 of 1000+
- 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review
- Steroid 5α-Reductase Inhibitors
- Localization of Plasminogen Activator Inhibitor Type 2 (PAI-2) in Hair and Nail: Implications for Terminal Differentiation
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- 17β-Estradiol Inhibits Wound Healing in Male Mice via Estrogen Receptor-α
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- 5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia
- A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- A Small Molecule Inhibitor Partitions Two Distinct Pathways for Trafficking of Tonoplast Intrinsic Proteins in Arabidopsis
- Effects of PNU157706, a Dual 5α-Reductase Inhibitor, on Rat Epididymal Sperm Maturation and Fertility1
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- Long-term Oral Administration of 5α-reductase Inhibitor Attenuates Erectile Function by Inhibiting Autophagy and Promoting Apoptosis of Smooth Muscle Cells in Corpus Cavernosum of Aged Rats
- <i>Curcuma aeruginosa</i>, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study
- Azasteroids as inhibitors of testosterone 5α-reductase in mammalian skin
- Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque.
- Development of Novel Mitochondrial Pyruvate Carrier Inhibitors to Treat Hair Loss
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Safety concerns regarding 5α reductase inhibitors for the treatment of androgenetic alopecia
- In Vitro and In Vivo Skin Distribution of 5α-Reductase Inhibitors Loaded Into Liquid Crystalline Nanoparticles
- Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review.
- Unique Cutaneous Reaction to Second- and Third-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia
- Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride
- Finasteride Treatment Inhibits Adult Hippocampal Neurogenesis in Male Mice
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink
- Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study
- 5α-Reductase inhibitors in androgenetic alopecia
- Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy